Arrowhead Pharmaceuticals
ARWR
#2104
Rank
NZ$16.72 B
Marketcap
NZ$118.41
Share price
2.96%
Change (1 day)
139.47%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): NZ$1.60

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ$1.42. In 2025 the company made an earnings per share (EPS) of NZ-$0.01748 an increase over its 2024 EPS that were of NZ-$8.74.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.60-9245.28%
2025NZ-$0.01748-99.8%
2024NZ-$8.74161.39%
2023NZ-$3.3417.36%
2022NZ-$2.8519.85%
2021NZ-$2.3861.9%
2020NZ-$1.47-216.67%
2019NZ$1.26-210.77%
2018NZ-$1.1438.3%
2017NZ-$0.82-64.93%
2016NZ-$2.34-16.25%
2015NZ-$2.8028%
2014NZ-$2.19-3.85%
2013NZ-$2.27-31.58%
2012NZ-$3.32331.82%
2011NZ-$0.77-51.11%
2010NZ-$1.57-79.07%
2009NZ-$7.52-37.68%
2008NZ-$12.06-16.87%
2007NZ-$14.5138.33%
2006NZ-$10.49122.22%
2005NZ-$4.7242.11%
2004NZ-$3.32533.33%
2003NZ-$0.52-99.08%
2002NZ-$56.7525%
2001NZ-$45.4033.33%
2000NZ-$34.05-120%
1999NZ$170.26-400%
1998NZ-$56.75-81.48%
1997NZ-$306.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.27 978.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ-$14.25-1,106.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$13.70 867.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$6.62 367.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ-$3.97-380.25%๐Ÿ‡บ๐Ÿ‡ธ USA